Andrea Botticelli | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
The Role of the CDK4/6 Inhibitor Ribociclib in Locally Advanced and Oligometastatic Hormone Receptor Positive, Her2 Negative, Advanced Breast Cancer: Case Series and Review of the Literature	FRONTIERS IN ONCOLOGY	2022
Renal function outcomes in metastatic non-small-cell lung carcinoma patients treated with chemotherapy or immune checkpoint inhibitors: an unexpected scenario	VACCINES	2022
Dental Implant Failure Risk in Post Oncological Patients, a Retrospective Study and Sapienza Head and Neck Unit Decisional Protocol- 7 Years of Follow-Up	DIAGNOSTICS	2022
Dental Implant Failure Risk in Post Oncological Patients, a Retrospective Study and Sapienza Head and Neck Unit Decisional Protocol- 7 Years of Follow-Up	DIAGNOSTICS	2022
Overexpression in metastatic breast cancer supports Syndecan-1 as a marker of invasiveness and poor prognosis	CLINICAL AND EXPERIMENTAL MEDICINE	2022
Cetuximab: Its role in patients unfit for cisplatin	ORAL ONCOLOGY	2022
127P {RAS}, {RAF} and {NF}1 oncogenic mutations in {KRAS}-mutated lung adenocarcinoma	ANNALS OF ONCOLOGY	2022
Precision medicine in breast cancer: do MRI biomarkers identify patients who truly benefit from the Oncotype DX Recurrence Score® Test?	DIAGNOSTICS	2022
Soluble PD-L1 as a prognostic factor for Immunotherapy treatment in solid tumors: Systematic review and Meta-Analysis	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2022
Genomic and immune approach in platinum refractory HPV-negative head and neck squamous cell carcinoma patients treated with Immunotherapy: a novel combined profile	BIOMEDICINES	2022
The role of immune profile in predicting outcomes in cancer patients treated with immunotherapy	FRONTIERS IN IMMUNOLOGY	2022
Oral immune-related adverse events associated with PD-1 inhibitor treatment: a case series	APPLIED SCIENCES	2022
DNA damage response and repair (DDR) gene mutations as an alternative mechanism to generate high TMB in never smoker NSCLC patients	ANNALS OF ONCOLOGY	2022
Antibiotics, the microbiome and gastrointestinal cancers: a causal interference?	CURRENT OPINION IN PHARMACOLOGY	2022
Ideal regimen for induction chemotherapy in nasopharyngeal cancer: Still a hot issue?	RADIOTHERAPY AND ONCOLOGY	2022
A regional survey on Merkel cell carcinoma: a plea for uniform patient journey modeling and diagnostic–therapeutic pathway	CURRENT ONCOLOGY	2022
The Impact of the Hippo Pathway and Cell Metabolism on Pathological Complete Response in Locally Advanced Her2+ Breast Cancer: The TRISKELE Multicenter Prospective Study	CANCERS	2022
Definition of High-Risk Early Hormone-Positive HER2−Negative Breast Cancer: A Consensus Review	CANCERS	2022
Definition of High-Risk Early Hormone-Positive HER2−Negative Breast Cancer: A Consensus Review	CANCERS	2022
Cetuximab: Its role in patients unfit for cisplatin	ORAL ONCOLOGY	2022

Progetti di Ricerca

Window therapy with CDK 4/6 inhibitors in head and neck cancer patients treated with immunotherapy